Table 1 Baseline demographic and clinical characteristics

From: Digital intervention mylovia improves sexual functioning in women with sexual dysfunction in randomized controlled trial

Variable

Control (n = 123)

Intervention (n = 129)

Age (mean, SD)

34.6 (9.5)

34.5 (9.9)

Education [completed university studies], n (%)

75 (61.0)

69 (53.5)

Employment [part- or full time], n (%)

90 (73.2)

92 (71.3)

Partnership situation [single], n (%)

15 (12.2)

13 (10.1)

Diagnosis (multiple possible)

Sexual pain-penetration disorder, n (%)

46 (37.4)

41 (31.8)

Hypoactive sexual desire dysfunction n (%)

70 (56.9)

86 (66.7)

Sexual arousal dysfunction, n (%)

37 (30.1)

42 (32.6)

Anorgasmia, n (%)

80 (65.0)

66 (51.2)

Sexual orientation [heterosexual], n (%)

99 (80.5)

103 (79.8)

Menopause status [pre], n (%)

103 (83.7)

109 (84.5)

In psychotherapy [yes], n (%)

26 (21.1)

26 (20.2)

In psychotherapy for sexual dysfunction/sexual pain disorder [yes], n (%)

4 (3.3)

4 (3.1)

History of sexual abuse [yes, as assessed in DISEX], n (%)

31 (25.2)

42 (32.6)

Contraceptive method [hormonal], n (%)

32 (26.0)

30 (23.3)